Back
Beam Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
BEAM
Beam Therapeutics, Inc.
Last Price:
$26.92
Seasonality Move:
-33.05%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BEAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Beam Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.66 | Buy |
| 20-day SMA: | 29 | Sell |
| 50-day SMA: | 28.39 | Sell |
| 200-day SMA: | 22.54 | Buy |
| 8-day EMA: | 27.01 | Sell |
| 20-day EMA: | 28.06 | Sell |
| 50-day EMA: | 27.84 | Sell |
| 200-day EMA: | 24.75 | Buy |
Beam Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 45.29 | Sell |
| Chaikin Money Flow: | 1772207 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.69 - 32.43) | Sell |
| Bollinger Bands (100): | (23.46 - 29.52) | Buy |
Beam Therapeutics, Inc. Technical Analysis
| Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Beam Therapeutics, Inc. Stock
Is Beam Therapeutics, Inc. Stock a Buy?
-
Beam Therapeutics, Inc. share price is 26.93 while BEAM 8-day simple moving average is 26.66, which is a Buy signal.
-
The stock price of BEAM is 26.93 while Beam Therapeutics, Inc. 20-day SMA is 29.00, which makes it a Sell.
-
Beam Therapeutics, Inc. 50-day simple moving average is 28.39 while BEAM share price is 26.93, making it a Sell technically.
-
BEAM stock price is 26.93 and Beam Therapeutics, Inc. 200-day simple moving average is 22.54, creating a Buy signal.
BEAM Technical Analysis vs Fundamental Analysis
Sell
47
Beam Therapeutics, Inc. (BEAM)
is a Sell
Is Beam Therapeutics, Inc. a Buy or a Sell?
-
Beam Therapeutics, Inc. stock is rated a SellThe current Beam Therapeutics, Inc. [BEAM] share price is $26.93. The Score for BEAM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Beam Therapeutics, Inc. Stock Info
Market Cap:
2.7B
Price in USD:
26.93
Share Volume:
2M
Beam Therapeutics, Inc. 52-Week Range
52-Week High:
36.44
52-Week Low:
13.53
Sell
47
Beam Therapeutics, Inc. (BEAM)
is a Sell
Beam Therapeutics, Inc. Share Price Forecast
-
What is the Beam Therapeutics, Inc. stock price today?The Beam Therapeutics, Inc. stock price is 26.93 USD today.
-
Will BEAM stock go up or go down?Beam Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Beam Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics, Inc. is overvalued.
Is Beam Therapeutics, Inc. Stock a Buy?
-
Beam Therapeutics, Inc. share price is 26.93 while BEAM 8-day exponential moving average is 27.01, which is a Sell signal.
-
The stock price of BEAM is 26.93 while Beam Therapeutics, Inc. 20-day EMA is 28.06, which makes it a Sell.
-
Beam Therapeutics, Inc. 50-day exponential moving average is 27.84 while BEAM share price is 26.93, making it a Sell technically.
-
BEAM stock price is 26.93 and Beam Therapeutics, Inc. 200-day simple moving average is 24.75, creating a Buy signal.
Fundamental Analysis of Beam Therapeutics, Inc.
Is Beam Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and an increase next year of $0.04 per share.
Technical Analysis of Beam Therapeutics, Inc.
Should I short Beam Therapeutics, Inc. stock?
-
BEAM Moving Average Covergence Divergence (MACD) indicator is -0.74, suggesting Beam Therapeutics, Inc. is a Sell
-
Beam Therapeutics, Inc. Relative Strength Index (RSI) is 45.29, which suggest Beam Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Beam Therapeutics, Inc. is (26.69 - 32.43), which suggest Beam Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Beam Therapeutics, Inc. is (23.46 - 29.52), which suggest Beam Therapeutics, Inc. is a Buy
* Beam Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.